ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy Study of Triamcinolone Acetonide DuraPeel to Treat Hand Dermatitis (TAC-202)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00890968
Recruitment Status : Completed
First Posted : April 30, 2009
Last Update Posted : March 16, 2012
Sponsor:
Information provided by (Responsible Party):
ZARS Pharma Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2009
  Actual Study Completion Date : August 2009
  Certification/Extension First Submitted : March 14, 2012